Hurwitz LM - Search Results

1

Longitudinal regret after treatment for low- and intermediate-risk prostate cancer.

Hurwitz LM, Cullen J, Kim DJ, Elsamanoudi S, Hudak J, Colston M, Travis J, Kuo HC, Rice KR, Porter CR, Rosner IL. Hurwitz LM, et al. Cancer. 2017 Nov 1;123(21):4252-4258. doi: 10.1002/cncr.30841. Epub 2017 Jul 5. Cancer. 2017. PMID: 28678408 Free article.

2

Reply to Prostate cancer multidisciplinary clinic and decisional regret: Looking for a longer follow-up.

Hurwitz LM, Cullen J. Hurwitz LM, et al. Cancer. 2017 Dec 15;123(24):4937-4939. doi: 10.1002/cncr.31053. Epub 2017 Oct 4. Cancer. 2017. PMID: 28976542 Free article. No abstract available.

3

Impact of Subsequent Biopsies on Comprehensive Health Related Quality of Life in Patients with and without Prostate Cancer.

Burns JF, Hurwitz LM, Levie KE, Caumont F, Brand TC, Rosner IL, Stroup S, Musser JE, Cullen J, Porter CR. Burns JF, et al. Among authors: hurwitz lm. J Urol. 2019 May;201(5):916-922. doi: 10.1097/JU.0000000000000024. J Urol. 2019. PMID: 30676475

4

A prospective study of health-related quality of life outcomes among men treated for intermediate- and high-risk prostate cancer: the impact of primary and secondary therapies.

Alsinnawi M, Cullen J, Hurwitz LM, Levie KE, Burns JF, Rosner IL, Brand TC, Stroup S, Sterbis JR, Rice K, Conti G, Porter CR. Alsinnawi M, et al. Among authors: hurwitz lm. Can J Urol. 2019 Aug;26(4):9809-9820. Can J Urol. 2019. PMID: 31469635

5

A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapy.

Caumont F, Conti G, Hurwitz LM, Kuo C, Levie KE, Badiozamani K, Frankel JK, Flores JP, Brand TC, Chaurasia A, Rosner IL, Stroup SP, Musser JE, Cullen J, Porter CR. Caumont F, et al. Among authors: hurwitz lm. Urol Oncol. 2020 Oct;38(10):794.e1-794.e9. doi: 10.1016/j.urolonc.2020.02.007. Epub 2020 Mar 3. Urol Oncol. 2020. PMID: 32139288

6

Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy.

Jeldres C, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Johnston RB, Pham KN, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Etzioni R, Porter CR. Jeldres C, et al. Among authors: hurwitz lm. Cancer. 2015 Jul 15;121(14):2465-73. doi: 10.1002/cncr.29370. Epub 2015 Apr 6. Cancer. 2015. PMID: 25845467 Free PMC article.

7

A prospective cohort study of treatment decision-making for prostate cancer following participation in a multidisciplinary clinic.

Hurwitz LM, Cullen J, Elsamanoudi S, Kim DJ, Hudak J, Colston M, Travis J, Kuo HC, Porter CR, Rosner IL. Hurwitz LM, et al. Urol Oncol. 2016 May;34(5):233.e17-25. doi: 10.1016/j.urolonc.2015.11.014. Epub 2015 Dec 15. Urol Oncol. 2016. PMID: 26705101

8

Prospective Quality of Life in Men Choosing Active Surveillance Compared to Those Biopsied but not Diagnosed with Prostate Cancer.

Pham KN, Cullen J, Hurwitz LM, Wolff EM, Levie KE, Odem-Davis K, Banerji JS, Rosner IL, Brand TC, L'Esperance JO, Sterbis JR, Porter CR. Pham KN, et al. Among authors: hurwitz lm. J Urol. 2016 Aug;196(2):392-8. doi: 10.1016/j.juro.2016.02.2972. Epub 2016 Mar 11. J Urol. 2016. PMID: 26976206

9

A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.

Banerji JS, Hurwitz LM, Cullen J, Wolff EM, Levie KE, Rosner IL, Brand TC, LʼEsperance JO, Sterbis JR, Porter CR. Banerji JS, et al. Among authors: hurwitz lm. Urol Oncol. 2017 May;35(5):234-242. doi: 10.1016/j.urolonc.2016.12.015. Epub 2017 Jan 19. Urol Oncol. 2017. PMID: 28110975

10

Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer.

Hammerich KH, Donahue TF, Rosner IL, Cullen J, Kuo HC, Hurwitz L, Chen Y, Bernstein M, Coleman J, Danila DC, Metwalli AR. Hammerich KH, et al. Urol Oncol. 2017 Jul;35(7):460.e21-460.e28. doi: 10.1016/j.urolonc.2017.02.001. Epub 2017 Apr 11. Urol Oncol. 2017. PMID: 28410987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters